Asitri Dashboard Search Clinical Trials
The U.S. National Library of Medicine provides a database of clinical trials worldwide. Use the fields below to search the database. Expand your results and select terms or phrases and right-click to search using Google, MalaCards, MedlinePlus, PubMed, or Wikipedia.
Saved Searches
Choose Search
Basic Search
Clinical Trials Search Results
Search History:
Count: 185
Selected: 0
| NCT ID | Title | ||
|---|---|---|---|
| NCT05968417 | Myeloma Novel Drug Discovery Ver 1.2 | ||
| NCT00499174 | Observation or Radical Treatment in Patients With Prostate Cancer | ||
| NCT02955082 | The BARCODE 2 Study - The Use of Genetic Profiling to Guide Prostate Cancer Treatment | ||
| NCT05097274 | The GENPET Study - An Imaging Study of FCH-PET-CT in Men With Prostate Cancer and a DNA Repair Gene Mutation. | ||
| NCT00005586 | Leucovorin and Fluorouracil Compared With Observation in Treating Patients With Colorectal Cancer That Has Been Surgically Removed | ||
| NCT07008742 | Feasibility Study of Tissue and Blood Collection in Oncogene-addicted and Neoadjuvantly Treated Non Small Cell Lung Cancer | ||
| NCT02587455 | Pembrolizumab and Palliative Radiotherapy in Lung | ||
| NCT06409221 | VISION: Triple Negative Breast Cancer Sample and Clinical Data Acquisition Study | ||
| NCT02070120 | Investigating Bladder Chemotherapy Instead of Surgery for Low Risk Bladder Cancer | ||
| NCT04763317 | Precision Medicine in the Prostate Cancer Care Pathway | ||
| NCT07002320 | Investigating SX-682 in Combination With Apalutamide in Metastatic Castration-resistant Prostate Cancer | ||
| NCT05782361 | POTENT - Tepotinib in Combination With Pembrolizumab in NSCLC | ||
| NCT03621332 | HRQoL in Advanced Soft Tissue Sarcoma Patients Treated With Chemotherapy. | ||
| NCT02447549 | Study of Tumour Focused Radiotherapy for Bladder Cancer | ||
| NCT04842799 | Digital Delivery of Information About Genetic Testing for Breast Cancer | ||
| NCT02759783 | Conventional Care Versus Radioablation (Stereotactic Body Radiotherapy) for Extracranial Oligometastases | ||
| NCT03466034 | The Role of Hypoxia as a Selective Pressure for TP53 Mutations | ||
| NCT02705846 | Analysing Outcomes After Prostate Cancer Diagnosis and Treatment in Carriers of Rare Germline Mutations | ||
| NCT04595019 | Hypofractionated Expedited Radiotherapy for Men With localisEd proState Cancer | ||
| NCT03262311 | Pimo Study: Extracellular Vesicle-based Liquid Biopsy to Detect Hypoxia in Tumours | ||
| NCT00299286 | Short-term Presurgical Study to Assess Molecular Predictors of Lapatinib's Effects in Primary Breast Cancer | ||
| NCT02296801 | A Phase II Randomized Study Evaluating the Biological and Clinical Effects of the Combination of Palbociclib With Letrozole as Neoadjuvant Therapy in Post-Menopausal Women With Estrogen-Receptor Positive Primary Breast Cancer | ||
| NCT00248521 | 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery | ||
| NCT01101438 | A Phase III Randomized Trial of Metformin vs Placebo in Early Stage Breast Cancer | ||
| NCT07098819 | The eValuation of Sources of vIBRAtioN for Vibrational Shear Wave elasTography | ||
| NCT00997464 | An Exploration of Genetic Testing for Prostate Cancer Susceptibility | ||
| NCT01006564 | Multifunctional Magnetic Resonance (MR) for Radiotherapy Planning in Prostate Cancer | ||
| NCT01693822 | A Phase II Study of Axitinib in Patients With Metastatic Renal Cell Cancer Unsuitable for Nephrectomy | ||
| NCT01332968 | A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM) | ||
| NCT05533190 | Clinical Investigation of Wysa | ||
| NCT02560636 | Pembrolizumab in Muscle Invasive/Metastatic Bladder Cancer | ||
| NCT00043004 | Chemotherapy and Bevacizumab With or Without Radiofrequency Ablation in Treating Unresectable Liver Metastases in Patients With Colorectal Cancer | ||
| NCT04151134 | Evaluation of Tongue Base MucOsectomy & Step sErial Sectioning | ||
| NCT04359420 | What Are the Benefits and Harms of Risk Stratified Screening in the NHS Breast Screening Programme: Study Protocol | ||
| NCT01964677 | MR-HIFU for Bone Metastases | ||
| NCT04985266 | A Trial of Early Detection of Molecular Relapse With Circulating Tumour DNA Tracking and Treatment With Palbociclib Plus Fulvestrant Versus Standard Endocrine Therapy in Patients With ER Positive HER2 Negative Breast Cancer | ||
| NCT01000129 | Adaptive Planning in Bladder Cancer | ||
| NCT00532727 | Triple Negative Breast Cancer Trial | ||
| NCT02714621 | MR-HIFU for Recurrent Gynaecological Cancer | ||
| NCT03673787 | A Trial of Ipatasertib in Combination With Atezolizumab | ||
| NCT05065086 | Single Modality Trans Oral Robotic Surgery for Primary Oropharyngeal Cancer: Exploring the Impact of Surgical Margins on Local Disease Recurrence | ||
| NCT00301925 | Combination Chemotherapy in Treating Patients With Early Stage Breast Cancer That Has Been Removed By Surgery | ||
| NCT06470685 | Prophylactic Prostatectomy for Prostate Cancer (PPPC) | ||
| NCT02409212 | Exercise Training as a Novel Primary Therapy for Men With Localised Prostate Cancer | ||
| NCT06423976 | Microbiome Molecular Charaterisation | ||
| NCT05082259 | ASTEROID: A Trial of ASTX660 in Combination With Pembrolizumab | ||
| NCT01331525 | The Addition of Ipilimumab to Carboplatin and Etoposide Chemotherapy for Extensive Stage Small Cell Lung Cancer | ||
| NCT02437227 | A Phase I, First in Man Study to Evaluate the Safety and Tolerability of a panRAF Inhibitor (CCT3833/BAL3833)in Patients With Solid Tumours | ||
| NCT06630260 | 5G-RUBY: Avutometinib and Defactinib in Malignant Brain Tumours | ||
| NCT05990192 | SBRT Alone or Followed by Niraparib for Oligometastases or Oligoprogression in Ovarian Cancer Following PARPi Therapy |
